Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 106 năm 2023

Outcomes of endovascular management of atherosclerotic peripheral artery disease at Dong Nai Provincial General Hospital

Võ Tuấn Anh: Bệnh viện Đa khoa Đồng Nai; Đặng Hà Hữu Phước: Bệnh viện Đa khoa Đồng Nai;
Published: August 1, 2023
Views: 128

Abstract

Introduction: Peripheral artery disease is a chronic disease with long-term progression and risk of disability. Treatment includes surgery and endovascular intervention, the latter is becoming more and more developed. This approach has good early and medium-term outcomes

Subjects: We report 58 cases of patients diagnosed with peripheral arterial disease who received endovascular intervention at Dong Nai General Hospital.

Results: 58 patients with peripheral vascular disease was treated with endovascular approach at Dong Nai General Hospital. Stenosis or chronic occlusion of the superficial femoral artery accounts for 60.3% of cases, the rest are stenosis of the subclavian artery, common iliac arteries and below-the-knee lesions. The primary intervention results were good, there were no serious complications, the rate of early vascular patency was 96.6%, the wound healing rate was 96.6%, 67.2% patients were stented after balloon angioplasty. No reintervention was needed in these patients.

Conclusion: The results of endovascular intervention for peripheral vascular disease at Dong Nai General Hospital are encouraging, this helps expanding the indications for intervention, including hybrid surgery and creating first steps in multidisciplinary treatment of cardiovascular disease, an new trend in the future.

References

1.
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e686-e725.
2.
Thukkani AK, Kinlay S. Endovascular intervention for peripheral artery disease. Circ Res. 2015;116(9):1599-613.
3.
Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816.
4.
Sixt S, Krankenberg H, Mohrle C, Kaspar M, Tubler T, Rastan A, et al. Endovascular treatment for extensive aortoiliac artery reconstruction: a single-center experience based on 1712 interventions. J Endovasc Ther. 2013;20(1):64-73.
5.
Kuntz S, Lejay A, Chakfe N. Subintimal Angioplasty in the Superficial Femoral Artery: A Real Long Term Option Demonstrated by Histology. EJVES Vasc Forum. 2021;52:49-50.
6.
Iida O, Urasawa K, Komura Y, Soga Y, Inoue N, Hara H, et al. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial. J Endovasc Ther. 2019;26(2):158-67.
7.
Warner CJ, Greaves SW, Larson RJ, Stone DH, Powell RJ, Walsh DB, et al. Cilostazol is associated with improved outcomes after peripheral endovascular interventions. J Vasc Surg. 2014;59(6):1607-14.
8.
Giannopoulos S, Lyden SP, Bisdas T, Micari A, Parikh SA, Jaff MR, et al. Endovascular Intervention for the Treatment of Trans-Atlantic Inter-Society Consensus (TASC) D Femoropopliteal Lesions: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021;22:52-65.
9.
Grenville JL, Tan KT, Moshonov H, Rajan DK. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center. Vascular. 2015;23(1):31-40.
10.
Joo HJ, Jang DH, Yu CW, Choi YJ, Park J, Lee HJ, et al. Efficacy and safety of endovascular treatment for femoropopliteal lesions of TASC II type C and D compared with TASC II type A and B in Korea. Vascular. 2017;25(4):351-8.
11.
Golledge J, Drovandi A, Velu R, Moxon J. Cohort study examining the relationship between remoteness and requirement for surgery to treat peripheral artery disease at a tertiary hospital in North Queensland. Aust J Rural Health. 2021;29(4):512-20.

Files

Article Views128
Document Views0
Downloads0
Section NGHIÊN CỨU LÂM SÀNG